
High-Dose MethotrexateLeucovorin Rescue. Must start within 24 hr of methotrexate.
- PO IM IV (Adults and Children ): Normal methotrexate elimination: 10 mg/m2 every 6 hr (1st dose IV/IM, then change to PO) until methotrexate level is <5 × 108 M (0.05 micromolar). Larger doses/longer duration may be required in patients with aciduria, ascites, dehydration, renal impairment, GI obstruction, pleural/peritoneal effusions. Dose of leucovorin should be determined on the basis of plasma methotrexate levels.
Advanced Colorectal Cancer
- IV (Adults ): 200 mg/m2 followed by 5-fluorouracil 370 mg/m2 or leucovorin 20 mg/m2 is followed by 5-fluorouracil 425 mg/m2. Regimen is given daily for 5 days every 45 wk.
Prevention of Hematologic Toxicity from Pyrimethamine
- PO IV (Adults and Children ): 515 mg/day.
Inadvertent Overdose of Folic Acid Antagonists
- IM IV (Adults and Children ): Methotrexatelarge doses: 75 mg IV followed by 12 mg IM every 6 hr for 4 doses; methotrexateaverage doses: 612 mg IM every 6 hr for 4 doses; other folic acid antagonists: amount equal in mg to folic acid antagonist.
Megaloblastic Anemia
- PO IM IV (Adults and Children ): Up to 1 mg/day (up to 6 mg/day for dihydrofolate reductase deficiency).
Therapeutic Classification: antidotes (for methotrexate), vitamins
Pharmacologic Classification: folic acid analogues
Absorption: Well absorbed (38%) following PO administration. ↓ bioavailability with larger doses. Oral absorption is saturated at doses >25 mg. Well absorbed following IM administration. IV administration results in complete bioavailability.
Distribution: Widely distributed to tissues. Concentrates in the CNS and liver.
Metabolism/Excretion: Extensively converted to tetrahydrofolic derivatives, including 5-methyltetrahydrofolate, a major storage form.
Half-Life: 3.5 hr.
(serum folate concentrations)
ROUTE | ONSET | PEAK | DURATION |
---|
PO | 2030 min | unknown | 36 hr |
IM | 1020 min | unknown | 36 hr |
IV | <5 min | unknown | 36 hr |